![Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice - ScienceDirect Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641120301144-ga1.jpg)
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice - ScienceDirect
![Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective ... Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective ...](https://www.hkmj.org/system/files/hkmj219439-table-3.jpg)
Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective ...
![Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter](https://pbs.twimg.com/media/ERubYcQWoAoe-z9.jpg)
Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter
![Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-51982-4/MediaObjects/41598_2019_51982_Fig1_HTML.png)
Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports
![Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial](https://www.frontiersin.org/files/Articles/820324/fonc-12-820324-HTML/image_m/fonc-12-820324-g001.jpg)
Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial
![The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy - ScienceDirect The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120633390-gr2.jpg)
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy - ScienceDirect
![Frontiers | Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage Frontiers | Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage](https://www.frontiersin.org/files/Articles/839475/fmed-09-839475-HTML-r2/image_m/fmed-09-839475-t001.jpg)
Frontiers | Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis - Document - Gale OneFile: Health and Medicine
![Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/278c632b7042bc327e3d3d2ca6440307ee7a11d8/3-Table2-1.png)
Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar
![Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter](https://pbs.twimg.com/media/FDHN0cBXoAYZ2On.jpg)
Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter
![Cancers | Free Full-Text | Maternal and Neonatal Outcome after the Use of G- CSF for Cancer Treatment during Pregnancy Cancers | Free Full-Text | Maternal and Neonatal Outcome after the Use of G- CSF for Cancer Treatment during Pregnancy](https://pub.mdpi-res.com/cancers/cancers-13-01214/article_deploy/html/images/cancers-13-01214-g001-550.jpg?1615788192)
Cancers | Free Full-Text | Maternal and Neonatal Outcome after the Use of G- CSF for Cancer Treatment during Pregnancy
![PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization:](https://0.academia-photos.com/attachment_thumbnails/42642917/mini_magick20190217-31973-d3ibz8.png?1550423490)